Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
19.75
+0.36 (1.86%)
At close: Apr 9, 2026, 4:00 PM EDT
19.56
-0.19 (-0.96%)
After-hours: Apr 9, 2026, 7:59 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 12 analysts that cover Hims & Hers Health stock have a consensus rating of "Hold" and an average price target of $29.33, which forecasts a 48.51% increase in the stock price over the next year. The lowest target is $18 and the highest is $68.
Price Target: $29.33 (+48.51%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 7 | 8 | 9 | 11 | 11 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $25 → $23 | Hold | Maintains | $25 → $23 | +16.46% | Mar 27, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $18 → $25 | Hold | Maintains | $18 → $25 | +26.58% | Mar 16, 2026 |
| Barclays | Barclays | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +46.84% | Mar 11, 2026 |
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $13 → $24 | Strong Sell → Hold | Upgrades | $13 → $24 | +21.52% | Mar 10, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $25 → $28 | Hold | Maintains | $25 → $28 | +41.77% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
2.82B
from 2.35B
Increased by 19.99%
Revenue Next Year
3.36B
from 2.82B
Increased by 19.20%
EPS This Year
0.58
from 0.51
Increased by 13.49%
EPS Next Year
0.64
from 0.58
Increased by 9.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.3B | 4.7B | |||
| Avg | 2.8B | 3.4B | |||
| Low | 2.4B | 2.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 41.0% | 66.4% | |||
| Avg | 20.0% | 19.2% | |||
| Low | 1.9% | -5.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.28 | 1.05 | ||
| Avg | 0.58 | 0.64 | ||
| Low | 0.17 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 150.1% | 80.6% | ||
| Avg | 13.5% | 9.9% | ||
| Low | -67.5% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.